All In MedTech

Device Trial Radar · NCT03715270

Evaluation of Tissue Oxygen Levels During Breast Reconstruction With a New Surgical Device

Prospective Non-randomized, Non-blinded, Convenience Sample to Evaluate the Surgical Imaging System

Last checked: Nov 21, 2026Latest source record: Jun 10, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

6

Actual

Start

Jan 30, 2019

Primary completion

Jun 5, 2019

Study completion Jun 5, 2019

Sponsor

Lead sponsor
Christie Medical Holdings, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 23, 2018

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is designed to evaluate the information provided to the clinicians by the surgical imaging device. It is also to gain insight on the user interface and how "user friendly" it is to the clinician.

Conditions

  • Perfusion; Complications

Interventions

  • Image surgical areaDevice

    Image surgical area

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Photographic, electronic and descriptive comparative analysis of superficial tissue oxygen saturation using Presygen™/si-1 for breast reconstruction subjects.Time frame: 24 hours.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Englewood Hospital and Medical Cetner

    Englewood, New Jersey

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.